Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Guile

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Veterinary Record|October 9, 2015
Veterinary team interactions, part one: the practice effectT Kinnison, S A May, D Guile
The Veterinary Record|October 24, 2015
Errors in veterinary practice: preliminary lessons for building better veterinary teamsT Kinnison, D Guile, S A May
The Veterinary Record|October 23, 2015
Veterinary team interactions, part 2: the personal effectT Kinnison, D Guile, S A May
Antioxidants (Basel, Switzerland)|July 29, 2023
New Insights on the Uptake and Trafficking of Coenzyme QMichael D Guile, Akash Jain, Kyle A Anderson, et al.
Organic Letters|September 14, 2001
Formal intramolecular [5 + 2] photocycloaddition reactions of maleimides: a novel approach to the CDE ring skeleton of (-)-cephalotaxineK I Booker-Milburn, L F Dudin, C E Anson, et al.
Progress in Medicinal Chemistry|January 5, 2002
The medicinal chemistry of the P2 receptor familyS D Guile, F Ince, A H Ingall, et al.
Journal of Medicinal Chemistry|February 5, 2009
Antagonists of the P2X(7) receptor. From lead identification to drug developmentSimon D Guile, Lilian Alcaraz, Timothy N Birkinshaw, et al.
Journal of Medicinal Chemistry|January 19, 2007
Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion propertiesSimon D Guile, John R Bantick, Martin E Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2006
Potent blockers of the monocarboxylate transporter MCT1: novel immunomodulatory compoundsS D Guile, J R Bantick, D R Cheshire, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosisBrian Springthorpe, Andrew Bailey, Patrick Barton, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Veterinary Record|October 9, 2015
Veterinary team interactions, part one: the practice effectT Kinnison, S A May, D Guile
The Veterinary Record|October 24, 2015
Errors in veterinary practice: preliminary lessons for building better veterinary teamsT Kinnison, D Guile, S A May
The Veterinary Record|October 23, 2015
Veterinary team interactions, part 2: the personal effectT Kinnison, D Guile, S A May
Antioxidants (Basel, Switzerland)|July 29, 2023
New Insights on the Uptake and Trafficking of Coenzyme QMichael D Guile, Akash Jain, Kyle A Anderson, et al.
Organic Letters|September 14, 2001
Formal intramolecular [5 + 2] photocycloaddition reactions of maleimides: a novel approach to the CDE ring skeleton of (-)-cephalotaxineK I Booker-Milburn, L F Dudin, C E Anson, et al.
Progress in Medicinal Chemistry|January 5, 2002
The medicinal chemistry of the P2 receptor familyS D Guile, F Ince, A H Ingall, et al.
Journal of Medicinal Chemistry|February 5, 2009
Antagonists of the P2X(7) receptor. From lead identification to drug developmentSimon D Guile, Lilian Alcaraz, Timothy N Birkinshaw, et al.
Journal of Medicinal Chemistry|January 19, 2007
Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion propertiesSimon D Guile, John R Bantick, Martin E Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2006
Potent blockers of the monocarboxylate transporter MCT1: novel immunomodulatory compoundsS D Guile, J R Bantick, D R Cheshire, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosisBrian Springthorpe, Andrew Bailey, Patrick Barton, et al.
Pageof 1